Mr. Woodward is a former investment banker with over 30 years of experience in capital markets and corporate finance. Mr. Woodward is the President of Conation Capital Corp., an investor in early stage technology companies.
He is a director, CEO, and President, of Advanced Proteome Therapeutics Corp. (APC-TSXV), a biotech company focused on simplifying and standardizing the production of antibody drug conjugates to treat cancer, using proprietary site-selective chemistries as protein modification technologies.
He is also the President, CEO and a director of Aether Catalyst Solutions, Inc. (ATHR-CSE), a developer of unique, low-cost catalysts for the abatement of automotive emissions.
Mr. Woodward is also a director of numerous private companies in which Conation has invested. He holds a Bachelor of Arts (Econ) from Simon Fraser University in Burnaby, British Columbia.